HIV infection and COVID-19 death: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform
暂无分享,去创建一个
K. Bhaskaran | L. Smeeth | R. Eggo | E. Williamson | A. Walker | S. Bacon | C. Bates | C. Morton | H. Curtis | A. Mehrkar | P. Inglesby | J. Cockburn | H. McDonald | B. MacKenna | I. Douglas | C. Rentsch | H. Forbes | J. Parry | F. Hester | S. Harper | S. Evans | B. Goldacre | A. Schultz | W. Hulme | K. Bhaskaran | D. Evans | Stephen Evans | D. Evans | John Parry | H. Mcdonald | B. Mackenna | Anna Schultz
[1] B. Woodward,et al. Coronavirus disease 2019 (COVID‐19) outcomes in HIV/AIDS patients: a systematic review , 2020, HIV medicine.
[2] K. Bhaskaran,et al. OpenSAFELY: factors associated with COVID-19 death in 17 million patients , 2020, Nature.
[3] M. Davies. HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa. , 2020, medRxiv : the preprint server for health sciences.
[4] Jessica K De Freitas,et al. Covid-19 and People with HIV Infection: Outcomes for Hospitalized Patients in New York City. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] J. Babik,et al. COVID-19 in Immunocompromised Hosts: What We Know So Far , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] M. Hernán,et al. Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy , 2020, Annals of Internal Medicine.
[7] K. Khunti,et al. The impact of ethnicity on clinical outcomes in COVID-19: A systematic review , 2020, EClinicalMedicine.
[8] Noga Shalev,et al. Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019 , 2020, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.
[9] R. López-Vélez,et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort , 2020, The Lancet HIV.
[10] F. Post,et al. Hospitalized Patients With COVID-19 and Human Immunodeficiency Virus: A Case Series , 2020, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.
[11] J. Sterne,et al. Collider bias undermines our understanding of COVID-19 disease risk and severity , 2020, Nature Communications.
[12] Felipe García,et al. COVID-19 in patients with HIV: clinical case series , 2020, The Lancet HIV.
[13] S. Kenmoe,et al. Case fatality rate and viral aetiologies of acute respiratory tract infections in HIV positive and negative people in Africa: The VARIAFRICA-HIV systematic review and meta-analysis , 2019, Journal of Clinical Virology.
[14] C. Leen,et al. Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study , 2017, The lancet. HIV.
[15] Krishnan Bhaskaran,et al. What is the difference between missing completely at random and missing at random? , 2014, International journal of epidemiology.
[16] M. Poulton. Patient confidentiality in sexual health services and electronic patient records , 2013, Sexually Transmitted Infections.
[17] P. Peters,et al. Influenza and HIV: Lessons from the 2009 H1N1 Influenza Pandemic , 2011, Current HIV/AIDS reports.
[18] Melania Pintilie,et al. Analysing and interpreting competing risk data , 2007, Statistics in medicine.
[19] K. Neuzil,et al. Influenza-associated morbidity and mortality in young and middle-aged women. , 1999, JAMA.
[20] R. Rudd,et al. Immunisation against infectious disease. , 1988, BMJ.
[21] R. Evans. European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).